Rhythm Biosciences Ltd has released a press release.
FY22 Strategic Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Rhythm Betters ColoSTAT Results
- Rhythm Extends ColoSTAT Clinical Trial to Western Australia
- Rhythm Retains ISO13485 Certification
- Study 6 Successfully Concluded - Exceptional Results
- Rhythm Expands ColoSTAT Clinical Trial To Tenth Site
Later from Rhythm Biosciences
- RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
- Rhythm to Present at MST Access Investor Conference
- Rhythm Establishes US Entity To Drive US Expansion Strategy
- Non renouneable rights issue prospectus
- Rights Issue Investor Presentation
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences